Procaps Colombia (IDBI-12431-02)

  • Colombia
Where the impacts of the investment may be experienced.
Financial Institutions
  • IDB Invest (IDBI)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Bank Risk Rating
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Dec 17, 2020
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
Procaps S.A.
The holder of the loan, grant, or other investment.
  • Industry and Trade
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
The categories of the bank investment: loan, grant, etc.
Investment Amount (USD)
$ 20.00 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Primary Source

Original disclosure @ IDBI website

Updated in EWS Dec 15, 2020

Disclosed by Bank Nov 13, 2020

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description

The proposed financing consists of a loan to Procaps S.A. ("Procaps" or "the Company") in an aggregate amount of up to US$20 million for a term of up to three years. The project aims to support the expansion plan of Procaps, a company dedicated to the development, production and marketing of pharmaceutical drugs and advanced drug delivery system. The loan will properly finance the Company's long cash cycles, reducing short-term pressure, and provide additional resources for continued Research and Development investment and capital expenditures, both regulatory and growth-related.

Investment Description
  • IDB Invest (IDBI)
Private Actors
Contact Information

For inquiries about the Project please contact:

Name: Sergio A. Mantilla Gómez

Title: CFO

Phone number: (575) 371 92 80

Email: or

For questions and comments to IDB Invest please contact:

Name: IDB Invest Communication Group


Affected communities can also access IDB Invest’s Independent Consultation and Investigation Mechanism (ICIM) as follows:

Phone number: + 1 (202) 623-3952

Fax number: +1 (202) 312-4057

Address: 1300 New York Ave. NW Washington, DC. USA. 20577

Email: or